Dr. Nandyal authored and co-authored a variety of topics including Neuro-developmental outcome of infants with Asphyxia- Hypoxic Ischemic Encephalopathy (HIE- multiple articles), Hyperbilirubinemia, Perinatal HIV- WI State guidelines (WAPC- Wisconsin Association for Perinatal Care- 1995, 2002), GBS Update, Late Preterm Infants (LPI- review article), Oklahoma Infant Alliance LPI guidelines, and National Perinatal Association LPI guidelines, Child maltreatment among Neonatal ICU graduates using OK Ca BI (multiple articles), Caffeine therapy and alkaline phosphatase levels, Transfusion associated NEC (TANEC), Commentary on Community violence and pregnancy outcomes, review articles on Hemolytic disease of Newborn, Blood transfusions, and Exchange transfusions, and case reports.
Dr. Nandyal also participated in prospective randomized control studies including Nasal Intermittent Positive Pressure Ventilation (NIPPV), and bench research- Bilirubin displacement of Bumetanide (Bilirubin binding tests- Saturation indices, Horse Radish Peroxidase assay and HABA).
CATCH Grant Project "Medical Home for Neonates”
Co-Investigator/mentor for a study on "Expanding the Pathophysiologic Relationship of Maternal Tobacco Exposure and Premature Rupture of Membranes” (2016- 2018).
Andhra Medical College, India MB, BS - 1970
Internship: Flexible/Rotating at King George Hospital, India - 1971
Dissertation in Internal Medicine Residency: Govt. General Hospital, Cardioversion and Management of Tachyarrythmias - 1975
Pediatric Residency: Mercy Hospital and Medical Center, University of Illinois Hospital, Chicago, IL - 1981
Neonatal-Perinatal Fellowship: Children's Hospital of Michigan and Hutzel Hospital, Wayne State University - 1986
Pediatrics- American Board of Pediatrics (Permanent)
Neonatal-Perinatal Medicine- Sub- Board of Neonatal- Perinatal Medicine American Board Of Pediatrics (Recertified and up-to-date until 2027)
Senior Disability Analyst and Diplomate- American Board of Disability Analysts (No. 7169; 2005- Permanent)
During their complicated and prolonged neonatal intensive care unit (NICU) stay, NICU babies receive multiple transfusions of various blood products. There are National guidelines for screening for infections, and blood group incompatibility. But, there are no such recommendations for routine screening of the donated blood and blood products for heavy metals, organophosphates, and nicotine products. Obviously there is a perceived widely spread critical knowledge gap, as they may have a contributing role in our patients’ morbidity and mortality.
For our study, We hypothesize that the levels of the tested heavy metals (aluminum, arsenic, beryllium, cadmium, manganese, mercury, nickel, and lead) and nicotine metabolite (cotinine) in the donated blood, will exceed the reported safety levels.
Specific Aim 1. To assess for the presence of 8 common heavy metals (aluminum, arsenic, beryllium, cadmium, manganese, mercury, nickel, and lead) and nicotine bi-products (Qualitative) in our donors’ blood, that is assigned to our level 4 NICU babies.
Specific Aim 2: To measure each of the tested metals and nicotine bi-products (quantitative), and compare (variance) with US EPA approved levels.
Select Honors & Accomplishments:
December 27, 2008, July 28, 2018 - Contribution to CME and Service Excellence Awards- Andhra Medical College Alumni of North America (AMCANA)
January 2017 - Faculty of the Month, Block 6, 2016- 2017, Pediatric Residents
2015 - Honor and Recognition Awards, Central Oklahoma FIMR Committee, 2009
2014 - CATCH Planning Grant, American Academy of Pediatrics, 2014
2014 - Organ, Eye, and Tissue Donation Champion Award, OUMC and Children’s Hospital
2014 - Award of Excellence- Best Poster (mentor), University of Oklahoma College of Nursing
2013 - Best Poster (mentor) Award- Research Day, Pediatrics Residency Program, Department of Pediatrics
2006 - 2007 - Outstanding Faculty Teaching Award, University of Oklahoma Health Sciences Center
- Nandyal, R. R. (2020). Co-authored- Neonatal Organ and Tissue Donation for Research: Options Following Death by Natural Causes. Cell Tissue Bank. DOI: https://doi.org/10.1007/s10561-020-09822-7
- Nandyal, R. R. (2019). Neonate with 10q Interstitial Deletion within the Long Arm of Chromosome 10- A Case Report and Literature Review. International Journal of Case Reports, 4:106(1), 1- 10.
- Nandyal, R. R. (2018). Neonatal exchange transfusion (NET) – what is its current net value? Journal of Blood Disorders and Treatment, 1(1), 9-13.
- Co-authored a chapter in a book- The Experience of Preterm Birth: Helping Families survive and thrive. Family Resilience and Chronic Illness: Interdisciplinary and Translational Perspectives (2017)